Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice

Published:2021-03-30 Issue:6 Volume:35 Page:3351-3364
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Li Junxiao¹,Liu Chuhe¹,Zhou Zhenyu¹,Dou Baokai¹,Huang Jinwen²,Huang Leilei²,Zheng Peiyong³,Fan Shengjie¹,Huang Cheng¹^ORCID

Affiliation:

1. School of Pharmacy Shanghai University of Traditional Chinese Medicine Shanghai China

2. School of Chemical and Environmental Engineering Shanghai Institute of Technology Shanghai China

3. Institute of Digestive Disease Longhua Hospital, Shanghai University of Traditional Chinese Medicine Shanghai China

Funder

Fok Ying Tung Education Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7055

Reference53 articles.

1. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis

2. Bile duct ligation: Step‐by‐step to cholangiocyte inflammatory tumorigenesis;Aller M. A.;European Journal of Gastroenterology and Hepatology,2010

3. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output

4. New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

5. Pathogenesis of carbon tetrachloride‐induced hepatocyte injury bioactivation of CCI4 by cytochrome P450 and effects on lipid homeostasis;Boll M.;Zeitschrift für Naturforschung. Teil C: Biochemie, Biophysik, Biologie, Virologie,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis;Journal of Controlled Release;2024-10

2. Gentiopicroside improves high-fat diet-induced NAFLD in association with modulation of host serum metabolome and gut microbiome in mice;Frontiers in Microbiology;2023-08-08

3. Discovery of a natural small-molecule AMP-activated kinase activator that alleviates nonalcoholic steatohepatitis;Marine Life Science & Technology;2023-04-30

4. Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease;Frontiers in Pharmacology;2022-11-02

5. Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis;Frontiers in Pharmacology;2022-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3